Breaking News

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.
Fireside chat details: | |||
Date: | Tuesday, April 13, 2021 | ||
Time: | 2:30 – 3:20 p.m. Eastern Time (ET) | ||
Panel title: | COVID-19 Vaccines – Staying Ahead of the Curve | ||
Novavax participant: | Vivek Shinde, M.D., M.P.H., Vice President, Clinical Development | ||
This event is open to Goldman Sachs clients. |
Companies In This Post
- Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
- Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
- Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
- Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
- Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more